Balchem (NASDAQ:BCPC) Price Target Raised to $190.00

Balchem (NASDAQ:BCPC) had its price objective lifted by HC Wainwright from $185.00 to $190.00 in a report released on Monday morning, Benzinga reports. They currently have a buy rating on the basic materials company’s stock. HC Wainwright also issued estimates for Balchem’s Q4 2024 earnings at $1.10 EPS, FY2024 earnings at $4.01 EPS, Q1 2025 earnings at $1.06 EPS, Q2 2025 earnings at $1.09 EPS, Q3 2025 earnings at $1.14 EPS, Q4 2025 earnings at $1.19 EPS and FY2025 earnings at $4.47 EPS.

Separately, StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

Balchem Price Performance

Shares of NASDAQ:BCPC opened at $183.41 on Monday. Balchem has a 12 month low of $116.84 and a 12 month high of $186.03. The firm has a market capitalization of $5.96 billion, a P/E ratio of 49.30, a P/E/G ratio of 5.25 and a beta of 0.65. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. The company’s fifty day moving average price is $171.99 and its 200 day moving average price is $163.77.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Natixis Advisors LLC grew its holdings in shares of Balchem by 2.1% during the third quarter. Natixis Advisors LLC now owns 21,797 shares of the basic materials company’s stock worth $3,836,000 after buying an additional 453 shares during the last quarter. Zions Bancorporation N.A. lifted its position in Balchem by 17.2% during the 3rd quarter. Zions Bancorporation N.A. now owns 10,976 shares of the basic materials company’s stock worth $1,932,000 after acquiring an additional 1,612 shares during the period. Empower Advisory Group LLC grew its stake in shares of Balchem by 1.1% in the 3rd quarter. Empower Advisory Group LLC now owns 113,427 shares of the basic materials company’s stock valued at $19,963,000 after purchasing an additional 1,201 shares during the last quarter. Geneva Capital Management LLC increased its holdings in shares of Balchem by 1.7% in the third quarter. Geneva Capital Management LLC now owns 779,869 shares of the basic materials company’s stock valued at $137,257,000 after purchasing an additional 12,750 shares during the period. Finally, Victory Capital Management Inc. raised its stake in shares of Balchem by 129.7% during the third quarter. Victory Capital Management Inc. now owns 98,853 shares of the basic materials company’s stock worth $17,398,000 after purchasing an additional 55,822 shares during the last quarter. 87.91% of the stock is owned by hedge funds and other institutional investors.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.